Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening.

Publication Type:

Journal Article


Medical care, Volume 51, Issue 4, p.295-300 (2013)


2013, April 2013, Decision Making, Early Detection of Cancer, Evidence-Based Medicine, Health Policy, Humans, Incidence, Male, Prostatic Neoplasms, Public Health Sciences Division, Randomized Controlled Trials as Topic, Risk Assessment, United States


The US Preventive Services Task Force recently recommended against prostate-specific antigen screening for prostate cancer based primarily on evidence from the European Randomized Study of Screening for Prostate Cancer (ERSPC) and the US Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial.